Aditi Chopra

ResearcherID Scopus Author ID ORCID

Publication Activity (10 Years)

Years Active: 2019-2024
Publications (10 Years): 38

Top Topics

Escherichia Coli

Systematic Review

Prostate Cancer

Signaling Pathway

Top Venues

Critical reviews in microbiology

This page only lists publications with an associated author ORCID identifier.

Publications

Karthik Sivaraman, Eti Rajwar, Aditi Chopra, George Cherukara, Shubhankar Mehrotra, Namrata Datta, Bindhu Koshy
How effective is dentin autograft for socket preservation and implant site preparation: A systematic review protocol. F1000Research 13 (2024)
Sayantan Mukherjee, Aditi Chopra, Shaswata Karmakar, Subraya Giliyar Bhat
Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecular mechanisms. Critical reviews in microbiology (2024)
Karthik Sivaraman, Eti Rajwar, Aditi Chopra, George Cherukara, Shubhankar Mehrotra, Namrata Datta, Bindhu Koshy
How effective is dentin autograft for socket preservation and implant site preparation: A systematic review protocol. F1000Research 13 (2024)
Aditi Chopra, Geeta Bhuvanagiri, Kshitija Natu, Avneesh Chopra
Role of CRISPR-Cas systems in periodontal disease pathogenesis and potential for periodontal therapy: A review. Molecular oral microbiology (2024)
Sayantan Mukherjee, Aditi Chopra, Shaswata Karmakar, Subraya Giliyar Bhat
Periodontitis increases the risk of gastrointestinal dysfunction: an update on the plausible pathogenic molecuar mechanisms. Critical reviews in microbiology (2024)
Karthik Sivaraman, Eti Rajwar, Aditi Chopra, George Cherukara, Shubhankar Mehrotra, Namrata Datta, Bindhu Koshy
How effective is dentin autograft for socket preservation and implant site preparation: A systematic review protocol. F1000Research 13 (2024)
Lakshmi Puzhankara, Avishikta Banerjee, Aditi Chopra, Venkitachalam Ramanarayanan, Madhurya N Kedlaya
Effectiveness of probiotics compared to antibiotics to treat periodontal disease: Systematic review. Oral diseases (2023)
Hasinthi Swarnamali, Nidhi Medara, Aditi Chopra, Axel Spahr, Thilini N Jayasinghe
Role of Dietary Fibre in Managing Periodontal Diseases-A Systematic Review and Meta-Analysis of Human Intervention Studies. Nutrients 15 (18) (2023)
Swagata Saha, Aditi Chopra, Shobha Ullas Kamath, Namita N Kashyap
Can acid produced from probiotic bacteria alter the surface roughness, microhardness, and elemental composition of enamel? An in vitro study. Odontology (2023)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Padacherri Vethil Jishnu, Sangeetha U Shenoy, Mohit Sharma, Aditi Chopra, Raghu A Radhakrishnan
Comprehensive analysis of microRNAs and their target genes in oral submucous fibrosis. Oral diseases (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Amee Sanghavi, Ananth Srivatsa, Divya Adiga, Aditi Chopra, Richard Lobo, Shama Prasada Kabekkodu, Shivaprasada Gadag, Usha Nayak, Karthik Sivaraman, Ashmeet Shah
Goji berry (Lycium barbarum) inhibits the proliferation, adhesion, and migration of oral cancer cells by inhibiting the ERK, AKT, and CyclinD cell signaling pathways: an in-vitro study. F1000Research 11 (2022)
Aditi Chopra, Thilini N Jayasinghe, Joerg Eberhard
Are Inflamed Periodontal Tissues Endogenous Source of Advanced Glycation End-Products (AGEs) in Individuals with and without Diabetes Mellitus? A Systematic Review. Biomolecules 12 (5) (2022)
Aditi Chopra, Subraya G Bhat, Karthik Sivaraman
Porphyromonas gingivalis adopts intricate and unique molecular mechanisms to survive and persist within the host: a critical update. Journal of oral microbiology 12 (1) (2020)
Karthik Sivaraman, Aditi Chopra, Aparna Narayana, Raghu A Radhakrishnan
A five-step risk management process for geriatric dental practice during SARS-CoV-2 pandemic. Gerodontology 38 (1) (2020)
Aditi Chopra, Raghu Radhakrishnan, Mohit Sharma
Porphyromonas gingivalis and adverse pregnancy outcomes: a review on its intricate pathogenic mechanisms. Critical reviews in microbiology 46 (2) (2020)
Aditi Chopra, Karthik Sivaraman, Aparna I Narayan, Dhanasekar Balakrishnan
Etiology and classification of food impaction around implants and implant-retained prosthesis. Clinical implant dentistry and related research 21 (2) (2019)
Aditi Chopra, Karthik Sivaraman
An update on possible pathogenic mechanisms of periodontal pathogens on renal dysfunction. Critical reviews in microbiology 45 (5-6) (2019)